Madrigal Pharmaceuticals, Inc. (FRA:YDO1)

Market Cap	11.27B
Revenue (ttm)	631.25M
Net Income (ttm)	-246.42M
Shares Out	n/a
EPS (ttm)	-11.11
PE Ratio	n/a
Forward PE	126.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	7
Open	498.00
Previous Close	504.80
Day's Range	491.30 - 498.00
52-Week Range	229.50 - 523.20
Beta	n/a
RSI	67.06
Earnings Date	Feb 25, 2026

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

• Industry: Pharmaceutical Preparations
• CEO: William Sibold
• Employees: 528
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: YDO1

Financial Performance

Financial numbers in USD